Fusing R features and local features with context-aware kernels for action recognition

The performance of action recognition in video sequences depends significantly on the representation of actions and the similarity measurement between the representations. In this paper, we combine two kinds of features extracted from the spatio-temporal interest points with context-aware kernels for action recognition. For the action representation, local cuboid features extracted around interest points are very popular using a Bag of Visual Words (BOVW) model. Such representations, however, ignore potentially valuable information about the global spatio-temporal distribution of interest points. We propose a new global feature to capture the detailed geometrical distribution of interest points. It is calculated by using the 3D R transform which is defined as an extended 3D discrete Radon transform, followed by the application of a two-directional two-dimensional principal component analysis. For the similarity measurement, we model a video set as an optimized probabilistic hypergraph and propose a context-aware kernel to measure high order relationships among videos. The context-aware kernel is more robust to the noise and outliers in the data than the traditional context-free kernel which just considers the pairwise relationships between videos. The hyperedges of the hypergraph are constructed based on a learnt Mahalanobis distance metric. Any disturbing information from other classes is excluded from each hyperedge. Finally, a multiple kernel learning algorithm is designed by integrating the l2 norm regularization into a linear SVM classifier to fuse the R feature and the BOVW representation for action recognition. Experimental results on several datasets demonstrate the effectiveness of the proposed approach for action recognition

Accurate Patient Alignment without Unnecessary Imaging Dose via Synthesizing Patient-specific 3D CT Images from 2D kV Images

In radiotherapy, 2D orthogonally projected kV images are used for patient alignment when 3D-on-board imaging(OBI) unavailable. But tumor visibility is constrained due to the projection of patient's anatomy onto a 2D plane, potentially leading to substantial setup errors. In treatment room with 3D-OBI such as cone beam CT(CBCT), the field of view(FOV) of CBCT is limited with unnecessarily high imaging dose, thus unfavorable for pediatric patients. A solution to this dilemma is to reconstruct 3D CT from kV images obtained at the treatment position. Here, we propose a dual-models framework built with hierarchical ViT blocks. Unlike a proof-of-concept approach, our framework considers kV images as the solo input and can synthesize accurate, full-size 3D CT in real time(within milliseconds). We demonstrate the feasibility of the proposed approach on 10 patients with head and neck (H&N) cancer using image quality(MAE: 97%) and patient position uncertainty(shift error: <0.4mm). The proposed framework can generate accurate 3D CT faithfully mirroring real-time patient position, thus significantly improving patient setup accuracy, keeping imaging dose minimum, and maintaining treatment veracity.Comment: 17 pages, 8 figures and table

First operational BRDF, albedo nadir reflectance products from MODIS

With the launch of NASA’s Terra satellite and the MODerate Resolution Imaging Spectroradiometer (MODIS), operational Bidirectional Reflectance Distribution Function (BRDF) and albedo products are now being made available to the scientific community. The MODIS BRDF/Albedo algorithm makes use of a semiempirical kernel-driven bidirectional reflectance model and multidate, multispectral data to provide global 1-km gridded and tiled products of the land surface every 16 days. These products include directional hemispherical albedo (black-sky albedo), bihemispherical albedo (white-sky albedo), Nadir BRDF-Adjusted surface Reflectances (NBAR), model parameters describing the BRDF, and extensive quality assurance information. The algorithm has been consistently producing albedo and NBAR for the public since July 2000. Initial evaluations indicate a stable BRDF/Albedo Product, where, for example, the spatial and temporal progression of phenological characteristics is easily detected in the NBAR and albedo results. These early beta and provisional products auger well for the routine production of stable MODIS-derived BRDF parameters, nadir reflectances, and albedos for use by the global observation and modeling communities

Chemiluminescence determination of surfactant Triton X-100 in environmental water with luminol-hydrogen peroxide system

<p>Abstract</p> <p>Background</p> <p>The rapid, simple determination of surfactants in environmental samples is essential because of the extensive use and its potential as contaminants. We describe a simple, rapid chemiluminescence method for the direct determination of the non-ionic surfactant Triton X-100 (polyethylene glycol tert-octylphenyl ether) in environmental water samples. The optimized experimental conditions were selected, and the mechanism of the Luminol-H₂O₂-Triton X-100 chemiluminesence system was also studied.</p> <p>Results</p> <p>The novel chemiluminescence method for the determination of non-ionic surfactant Triton X-100 was based on the phenomenon that Triton X-100 greatly enhanced the CL signal of the luminol-H₂O₂system. The alkaline medium of luminol and the pH value obviously affected the results. Luminol concentration and hydrogen peroxide concentration also affected the results. The optimal conditions were: Na₂CO₃being the medium, pH value 12.5, luminol concentration 1.0 × 10^-4mol L^-1, H₂O₂concentration 0.4 mol L^-1. The possible mechanism was studied and proposed.</p> <p>Conclusion</p> <p>Under the optimal conditions, the standard curve was drawn up and quotas were evaluated. The linear range was 2 × 10^-4g·mL^-1-4 × 10^-2g·mL^-1(w/v), and the detection limit was 3.97 × 10^-5g·mL^-1Triton X-100 (w/v). The relative standard deviation was less than 4.73% for 2 × 10^-2g·mL^-1(w/v) Triton X-100 (n = 7). This method has been applied to the determination of Triton X-100 in environmental water samples. The desirable recovery ratio was between 96%–102% and the relative standard deviation was 2.5%–3.3%. The luminescence mechanism was also discussed in detail based on the fluorescence spectrum and the kinetic curve, and demonstrated that Triton X-100-luminol-H₂O₂was a rapid reaction.</p

Cloning and Functional Analysis of FLJ20420: A Novel Transcription Factor for the BAG-1 Promoter

BAG-1 is an anti-apoptotic protein that interacts with a variety of cellular molecules to inhibit apoptosis. The mechanisms by which BAG-1 interacts with other proteins to inhibit apoptosis have been extensively explored. However, it is currently unknown how BAG-1 expression is regulated at the molecular level, especially in cancer cells. Here we reported to clone a novel down-regulated BAG-1 expression gene named FLJ20420 using hBAG-1 promoter as a probe to screen Human Hela 5′ cDNA library by Southernwestern blot. The FLJ20420 gene encodes a ∼26-kDa protein that is localized in both the cytoplasm and nucleus. We proved that FLJ20420 protein can specially bind hBAG-1 promoter region by EMSA in vivo and ChIP assay in vivo. Northern blot analysis revealed a low level of FLJ20420 transcriptional expression in normal human tissues (i.e., brain, placenta, lung, liver, kidney, pancreas and cervix), except for heart and skeletal muscles, which showed higher levels. Furthermore, enhanced FLJ20420 expression was observed in tumor cell lines (i.e., MDA468, BT-20, MCF-7, C33A, HeLa and Caski). Knockdown of endogenous FLJ20420 expression significantly increased BAG-1 expression in A549 and L9981 cells, and also significantly enhanced their sensitivity to cisplatin-induced apoptosis. A microarray assay of the FLJ20420 siRNA –transfectants showed altered expression of 505 known genes, including 272 upregulated and 233 downregulated genes. Finally, our gene array studies in lung cancer tissue samples revealed a significant increase in FLJ20420 expression in primary lung cancer relative to the paired normal lung tissue controls (p = 0.0006). The increased expression of FLJ20420 corresponded to a significant decrease in BAG-1 protein expression in the primary lung cancers, relative to the paired normal lung tissue controls (p = 0.0001). Taken together, our experiments suggest that FLJ20420 functions as a down-regulator of BAG-1 expression. Its abnormal expression may be involved in the oncogenesis of human malignancies such as lung cancer

Role of the Paraventricular Nucleus of the Hypothalamus in the Sympathoexcitatory Effects of Leptin

Leptin binds to receptors in multiple hypothalamic nuclei to increase sympathetic nerve activity; however, the neurocircuitry is unclear. Here, using anesthetized male Sprague–Dawley rats, we investigated the role of the paraventricular nucleus of the hypothalamus. Intracerebroventricular injection of leptin slowly increased lumbar sympathetic nerve activity (LSNA), heart rate, mean arterial pressure, and baroreflex control of LSNA and heart rate. Inhibition of the paraventricular nucleus with muscimol completely reversed leptin’s effects. Blockade of paraventricular melanocortin 3/4 receptors with SHU9119 or ionotropic glutamate receptors with kynurenate, alone or together, each partially reversed the effects of leptin, implicating increased activation of glutamate and melanocortin 3/4 receptors. Conversely, although blockade of neuropeptide Y Y1 receptors in the paraventricular nucleus increased LSNA, mean arterial pressure, and heart rate, these responses were prevented by intracerebroventricular or arcuate nucleus injections of leptin, suggesting that, at least in part, leptin also increases sympathetic nerve activity by suppression of tonic neuropeptide Y inhibitory inputs from the arcuate nucleus. Injection of the melanocortin 3/4 receptor agonist melanotan-II into the paraventricular nucleus increased LSNA, mean arterial pressure, and heart rate only after blockade of neuropeptide Y Y1 receptors. Therefore, we conclude that leptin increases LSNA in part via increased glutamatergic and α-melanocyte–stimulating hormone drive of paraventricular sympathoexcitatory neurons, the latter of which requires simultaneous withdrawal of tonic neuropeptide Y inhibition.</jats:p